An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition
Not available.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850163665720836096 |
|---|---|
| author | Iman Sarami Amy S. Duffield Suchitra Sundaram Douglas I. Lin Christian Salib Shafinaz Hussein Siraj El Jamal Nasrin Ghesani Busra Cangut Bruce E. Petersen |
| author_facet | Iman Sarami Amy S. Duffield Suchitra Sundaram Douglas I. Lin Christian Salib Shafinaz Hussein Siraj El Jamal Nasrin Ghesani Busra Cangut Bruce E. Petersen |
| author_sort | Iman Sarami |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-e87bfa3d7cf347089b90392d19aeb244 |
| institution | OA Journals |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-e87bfa3d7cf347089b90392d19aeb2442025-08-20T02:22:10ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-06-01999110.3324/haematol.2024.285776An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibitionIman Sarami0Amy S. Duffield1Suchitra Sundaram2Douglas I. Lin3Christian Salib4Shafinaz Hussein5Siraj El Jamal6Nasrin Ghesani7Busra Cangut8Bruce E. Petersen9Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TXDepartment of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NYDepartment of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NYFoundation Medicine, Cambridge, MADepartment of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NYDepartment of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NYDepartment of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJDepartment of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NYDepartment of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NYDepartment of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY Not available. https://haematologica.org/article/view/12133 |
| spellingShingle | Iman Sarami Amy S. Duffield Suchitra Sundaram Douglas I. Lin Christian Salib Shafinaz Hussein Siraj El Jamal Nasrin Ghesani Busra Cangut Bruce E. Petersen An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition Haematologica |
| title | An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition |
| title_full | An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition |
| title_fullStr | An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition |
| title_full_unstemmed | An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition |
| title_short | An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition |
| title_sort | aggressive hematolymphoid neoplasm with homozygous i smarcb1 i loss shows response to ezh2 inhibition |
| url | https://haematologica.org/article/view/12133 |
| work_keys_str_mv | AT imansarami anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT amysduffield anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT suchitrasundaram anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT douglasilin anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT christiansalib anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT shafinazhussein anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT sirajeljamal anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT nasringhesani anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT busracangut anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT bruceepetersen anaggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT imansarami aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT amysduffield aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT suchitrasundaram aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT douglasilin aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT christiansalib aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT shafinazhussein aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT sirajeljamal aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT nasringhesani aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT busracangut aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition AT bruceepetersen aggressivehematolymphoidneoplasmwithhomozygousismarcb1ilossshowsresponsetoezh2inhibition |